Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway
Journal of Cellular and Molecular Medicine · 2024-04 · 28 (8)
DOI: 10.1111/jcmm.18335 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, online erschienen am 23.04.2024. Verfasst von Jie Ji und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China. Hauptthemen laut MEDLINE: Ferroptosis, Artemisinins, Activating Transcription Factor 4, Carcinoma, Hepatocellular. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: China Postdoctoral Science Foundation, Shanghai Municipal Health Commission, The National Natural Science Foundation of China.
Abstract (Originalsprache)
Management of hepatocellular carcinoma (HCC) remains challenging due to population growth, frequent recurrence and drug resistance. Targeting of genes involved with the ferroptosis is a promising alternative treatment strategy for HCC. The present study aimed to investigate the effect of dihydroartemisinin (DHA) against HCC and explore the underlying mechanisms. The effects of DHA on induction of ferroptosis were investigated with the measurement of malondialdehyde concentrations, oxidised C11 BODIPY 581/591 staining, as well as subcutaneous xenograft experiments. Activated transcription factor 4 (ATF4) and solute carrier family 7 member 11 (SLC7A11 or xCT) were overexpressed with lentiviruses to verify the target of DHA. Here, we confirmed the anticancer effect of DHA in inducing ferroptosis is related to ATF4. High expression of ATF4 is related to worse clinicopathological prognosis of HCC. Mechanistically, DHA inhibited the expression of ATF4, thereby promoting lipid peroxidation and ferroptosis of HCC cells. Overexpression of ATF4 rescued DHA‐induced ferroptosis. Moreover, ATF4 could directly bound to the SLC7A11 promoter and increase its transcription. In addition, DHA enhances the chemosensitivity of sorafenib on HCC in vivo and in vitro. These findings confirm that DHA induces ferroptosis of HCC via inhibiting ATF4‐xCT pathway, thereby providing new drug options for the treatment of HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Shanghai Tenth People's Hospital, Tongji University School of Medicine, Shanghai, China.
- Department of Gastroenterology, Putuo People's Hospital, Tongji University, Shanghai, China.
- Department of Gastroenterology, Shidong Hospital, University of Shanghai for Science and Technology, Shanghai, China.
ORCID-Profile: Xuanfu Xu, Chuanyong Guo, Jiao Feng
Förderung
- China Postdoctoral Science Foundation
- Shanghai Municipal Health Commission
- The National Natural Science Foundation of China
- The Science and Technology Innovation Project of Shanghai Putuo District Health System
- The Yangfan Project of Shanghai Science and Technology Commission
- National Natural Science Foundation of China
Zitieren
APA
Ji, J., Cheng, Z., Zhang, J., Wu, J., Xu, X., Guo, C., & Feng, J. (2024). Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway. Journal of Cellular and Molecular Medicine, 28(8). https://doi.org/10.1111/jcmm.18335
Vancouver
Ji J, Cheng Z, Zhang J, Wu J, Xu X, Guo C, et al. Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway. Journal of Cellular and Molecular Medicine. 2024;28(8). doi:10.1111/jcmm.18335
BibTeX
@article{Ji2024,
author = {Ji, Jie and Cheng, Ziqi and Zhang, Jie and Wu, Jianye and Xu, Xuanfu and Guo, Chuanyong and Feng, Jiao},
title = {Dihydroartemisinin induces ferroptosis of hepatocellular carcinoma via inhibiting ATF4‐xCT pathway},
journal = {Journal of Cellular and Molecular Medicine},
year = {2024},
volume = {28},
number = {8},
doi = {10.1111/jcmm.18335}
}
EUVIMED